# Intraoperative Posterior Cruciate Ligament (Transcruciate) Injection After Total Knee Arthroplasty (TKA)

> **NCT01345604** · PHASE4 · COMPLETED · sponsor: **University of Saskatchewan** · enrollment: 50 (actual)

## Conditions studied

- Arthroplasty, Replacement, Knee

## Interventions

- **PROCEDURE:** transcruciate injection of 20cc of normal saline
- **PROCEDURE:** transcruciate injection of 20 cc of 0.5% Ropivacaine

## Key facts

- **NCT ID:** NCT01345604
- **Lead sponsor:** University of Saskatchewan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01345604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01345604, "Intraoperative Posterior Cruciate Ligament (Transcruciate) Injection After Total Knee Arthroplasty (TKA)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01345604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*